Research Paper Volume 13, Issue 4 pp 5638—5649
Long non-coding RNA TP73-AS1 is a potential immune related prognostic biomarker for glioma
Figure 3. Kaplan-meier analysis of TP73-AS1. (A–D) Kaplan-Meier analysis of OS for the expression of TP73-AS1 in all WHO grades in the TCGA primary glioma dataset (A), CGGA primary glioma dataset (B), CGGA recurrent glioma dataset (C), and GSE16011 primary glioma dataset (D). (E–H) Kaplan-Meier analysis of OS for the expression of TP73-AS1 in WHO grade II in the TCGA primary glioma dataset (E), CGGA primary glioma dataset (F), CGGA recurrent glioma dataset (G), and GSE16011 primary glioma dataset (H). (I–L) Kaplan-Meier analysis of OS for the expression of TP73-AS1 in WHO grade III in the TCGA primary glioma dataset (I), CGGA primary glioma dataset (J), CGGA recurrent glioma dataset (K), and GSE16011 primary glioma dataset (L). (M–P) Kaplan-Meier analysis of OS for the expression of TP73-AS1 in WHO grade IV in TCGA primary glioma dataset (M), CGGA primary glioma dataset (N), CGGA recurrent glioma dataset (O), and GSE16011 primary glioma dataset (P).